Daniel L. Kreisler

Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY.

Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL.

Acton Pharmaceuticals, Inc. developed and commercialized pharmaceutical products. The company was founded by John W. Simon and Daniel L. Kreisler in 2008 and is headquartered in Marlborough, MA.

TONIX Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Seth Lederman and Daniel L. Kreisler on June 7, 2007 and is headquartered in New York, NY.

Noven Therapeutics LLC develops and distributes pharmaceutical products. It markets products which include Pexeva used for major depressive disorder, panic disorder (PD), obsessive compulsive disorder (OCD) and Lithobid for bipolar disorder. The company was founded by Phillip M. Satow and Michael S. Satow in 2003 and is headquartered in New York, NY.